ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway

• Main Authors: Yu-Li Shen (Author), Yi-ping Jiang (Author), Xiao-Qin Li (Author), Su-Juan Wang (Author), Ming-Hua Ma (Author), Chun-Yan Zhang (Author), Jian-Yong Zhu (Author), Khalid Rahman (Author), Li-Jun Zhang (Author), Xin Luan (Author), Hong Zhang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2020-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Diabetic nephropathy (DN) is one of the main causes of renal fibrosis and is associated with high morbidity and mortality. Traditional Chinese Medicine (TCM) therapy has a long history of usage in a clinical setting and its usage is increasing. ErHuang Formula (EHF), a Chinese herbal compound, has b...